tradingkey.logo

ALZpath Inc - Signs Licensing Agreement with Siemens Healthineers

ReutersDec 15, 2025 1:40 PM

- ALZPATH INC:

  • ALZPATH AND SIEMENS HEALTHINEERS SHLG.DE SIGN LICENSING AGREEMENT TO ADVANCE GLOBAL ACCESS TO BLOOD-BASED ALZHEIMER'S DISEASE DIAGNOSTIC TESTING

  • LICENSING FOR USE OF ITS PROPRIETARY PTAU217 ANTIBODY IN DEVELOPMENT OF A PTAU217 ASSAY IN EXPANDING MENU OF SIEMENS HEALTHINEERS IN VITRO DIAGNOSTIC (IVD) TESTS FOR ALZHEIMER'S DISEASE

Further company coverage: []

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI